Curcumin and Function in Older Adults

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 11, 2017

Primary Completion Date

October 18, 2019

Study Completion Date

October 18, 2019

Conditions
Older AdultsPhysical FunctionCognitive Function
Interventions
DRUG

Curcumin

Participants will be given curcumin (1000 mg/day), and will be instructed to consume two 500 mg capsules prior to breakfast every morning with a glass of water. Participants will be instructed to follow this dosing regimen throughout the entire three-month treatment period. Compliance with the dosing regimen will be monitored both through interview and by counting capsules left at monthly clinic visits.

DRUG

microcrystalline cellulose

Participants will be instructed to consume two capsules prior to breakfast every morning with a glass of water. Participants will be instructed to follow this dosing regimen throughout the entire three-month treatment period. Compliance with the dosing regimen will be monitored both through interview and by counting capsules left at monthly clinic visits.

Trial Locations (1)

32611

University of Florida, Gainesville

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Florida

OTHER

NCT03085680 - Curcumin and Function in Older Adults | Biotech Hunter | Biotech Hunter